Literature DB >> 7760985

DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein.

R P Warren1, J Yonk, R W Burger, D Odell, W L Warren.   

Abstract

Autism is a developmental disorder characterized by severe communication, social and behavioral abnormalities. Over the past several years a fair amount of evidence has accumulated suggesting that some cases of autism may be associated with immune abnormalities and with products of the HLA complex including the C4B gene located in the class III region of HLA. This study sought additional evidence for an association of autoimmune processes with autism by investigating the presence of activated T cells in 26 autistic subjects. Fourteen of the autistic subjects had DR+ T cells, an indicator of activated T cells, but none of the autistic subjects had T cells expressing the interleukin-2 receptor, another indicator of T cell activation. Similar findings of incomplete or partial T cell activation have been reported in autoimmune disorders and in a recent study of autism. In the current investigation, the DR+ T cells were not found to be associated with age of the autistic patients but were inversely correlated with a decreased plasma level of the C4B protein. In conclusion, this study provides additional evidence for the involvement of an autoimmune mechanism in autism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760985     DOI: 10.1159/000119172

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  23 in total

1.  Immunological treatments for autism.

Authors:  S Gupta
Journal:  J Autism Dev Disord       Date:  2000-10

Review 2.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

3.  Macrophage migration inhibitory factor and autism spectrum disorders.

Authors:  Elena L Grigorenko; Summer S Han; Carolyn M Yrigollen; Lin Leng; Yuka Mizue; George M Anderson; Erik J Mulder; Annelies de Bildt; Ruud B Minderaa; Fred R Volkmar; Joseph T Chang; Richard Bucala
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

Review 4.  Brief report: alternative approaches to the development of effective treatments for autism.

Authors:  B Rimland; S M Baker
Journal:  J Autism Dev Disord       Date:  1996-04

5.  Modeling an autism risk factor in mice leads to permanent immune dysregulation.

Authors:  Elaine Y Hsiao; Sara W McBride; Janet Chow; Sarkis K Mazmanian; Paul H Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 6.  Etiology of infantile autism: a review of recent advances in genetic and neurobiological research.

Authors:  G Trottier; L Srivastava; C D Walker
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

Review 7.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

8.  Altered T cell responses in children with autism.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac N Pessah; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2010-09-15       Impact factor: 7.217

9.  Family analysis of immunoglobulin classes and subclasses in children with autistic disorder.

Authors:  Mirko Spiroski; Vladimir Trajkovski; Dejan Trajkov; Aleksandar Petlichkovski; Olivija Efinska-Mladenovska; Slavica Hristomanova; Eli Djulejic; Meri Paneva; Jadranka Bozhikov
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

10.  Pathogenesis of autism: a patchwork of genetic causes.

Authors:  Elena L Grigorenko
Journal:  Future Neurol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.